期刊
INFLAMMATORY BOWEL DISEASES
卷 27, 期 8, 页码 1184-1200出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izaa352
关键词
inflammatory bowel disease; Crohn disease; ulcerative colitis; pathogenesis; biomarkers; proteomics; tissue
Inflammatory bowel disease is a global disease with challenges in understanding its complex pathogenesis and progression, leading to limited progress in diagnosis and treatment. Future studies are needed to comprehensively characterize the disease biology for early detection and monitoring of clinical outcomes.
Inflammatory bowel disease (IBD) has become a global disease encompassing a group of progressive disorders characterized by recurrent chronic inflammation of the gut with variable disease courses and complications. Despite recent advances in the knowledge of IBD pathophysiology, the elucidation of its etiopathology and progression is far from fully understood, requiring complex and multiple approaches. Therefore, limited clinical progress in diagnosis, assessment of disease activity, and optimal therapeutic regimens have been made over the past few decades. This review explores recent advances and challenges in tissue proteomics with an emphasis on biomarker discovery and better understanding of the molecular mechanisms underlying IBD pathogenesis. Future multi-omic studies are required for the comprehensive molecular characterization of disease biology in real time with a future impact on early detection, disease monitoring, and prediction of the clinical outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据